Summary

● On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.


Strengths

● The company's attractive earnings multiples are brought to light by a P/E ratio at 9.41 for the current year.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.68 for the 2026 fiscal year.

● The company's share price in relation to its net book value makes it look relatively cheap.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The company sustains low margins.

● The group shows a rather high level of debt in proportion to its EBITDA.

● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.

● For the past year, analysts have significantly revised downwards their profit estimates.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

● The group usually releases earnings worse than estimated.